• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Tonix Pharmaceuticals Holding Corp (TNXP)

    -NasdaqGM
    6.19 0.01(0.16%) Dec 26, 3:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development5,217  4,075  3,550  1,328  
    Selling General and Administrative2,217  1,974  1,619  2,381  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (7,434) (6,049) (5,169) (3,709)
    Income from Continuing Operations
    Total Other Income/Expenses Net -  5  5   -  
    Earnings Before Interest And Taxes(7,419)(6,044)(5,164)(3,707)
    Interest Expense -   -   -   -  
    Income Before Tax(7,419)(6,044)(5,164)(3,707)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(7,419)(6,044)(5,164)(3,707)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (7,419) (6,044) (5,164) (3,707)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (7,419) (6,044) (5,164) (3,707)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.